TrialClinical and translational medicine2024

Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.

Yuzhou Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.